CareDx (CDNA) Cost of Revenue (2013 - 2026)

CareDx (CDNA) has 14 years of Cost of Revenue data on file, last reported at $30.4 million in Q1 2026.

• Quarterly Cost of Revenue rose 32.11% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.0 million (up 29.23% YoY) and the FY2025 annual result came in at $102.6 million, up 25.21% from the prior year.
• Cost of Revenue eased to $30.4 million in Q1 2026 per CDNA's latest filing, from $30.9 million in the prior quarter.
• The five-year high for Cost of Revenue was $30.9 million in Q4 2025, with the low at $18.5 million in Q3 2023.
• Average Cost of Revenue over 5 years is $23.2 million, with a median of $23.0 million recorded in 2025.
• Year-over-year, Cost of Revenue soared 49.81% in 2022 and retreated 19.74% in 2023.
• CareDx's Cost of Revenue stood at $23.7 million in 2022, then declined by 12.43% to $20.7 million in 2023, then rose by 2.96% to $21.3 million in 2024, then soared by 44.9% to $30.9 million in 2025, then slipped by 1.78% to $30.4 million in 2026.
• Business Quant data shows CDNA's Cost of Revenue at $30.4 million in Q1 2026, $30.9 million in Q4 2025, and $24.4 million in Q3 2025.